Navigation Links
HealthEdge Receives $13 Million Investment Commitment to Fund Significant Growth
Date:4/22/2008

HealthEdge's Revolutionary Software Platform-HealthRules(R)-Poised to

Change the Rules for Healthcare Payors

BURLINGTON, Mass., April 22 /PRNewswire/ -- HealthEdge, the leading provider of next-generation claims and benefit administration, business intelligence and portal software products for healthcare payors, today announced that it has secured a $13 million investment commitment from Psilos Group, a leading healthcare venture capital and private equity firm.

"We believe that HealthEdge's HealthRules is the only software platform that meets the needs of today's healthcare marketplace," said Dr. Albert Waxman, senior managing member of Psilos Group. "The legacy systems currently in use at most health plans cannot respond to the evolving consumer-focused healthcare economy which demands support for personalized benefits and complex financial transaction management. HealthEdge is uniquely positioned to provide payor organizations of all sizes the ability to quickly offer the kinds of innovative products that the market demands and to make long overdue reductions in administrative overhead. Psilos is excited to extend our support of HealthEdge as it continues to expand its products and services."

"We are seeing unprecedented demand for our products," remarked Rob Gillette, CEO of HealthEdge. "The healthcare payor community has now realized that a contemporary software platform, built with the next generation of healthcare in mind, is no longer a luxury, but a necessity. We are extremely pleased to have Psilos Group as our investment partner."

HealthEdge will use the funds to increase the size of its business and to continue to invest in advanced product capabilities.

About HealthEdge

HealthEdge provides health plans, TPAs, PPOs and insurers of all sizes unique software products that enable them to compete in the new healthcare market. Payor organizations are able to pursue innovative, new strategies focused on increasing revenue, decreasing costs and improving the quality of healthcare. HealthEdge provides HealthRules(R), a next-generation, patented software platform for core administrative processes, business intelligence, and web self-service. The company is headquartered in Burlington, Massachusetts.

About Psilos Group

Psilos Group has been a successful healthcare venture capital and private equity firm since its founding in 1998. With over $500MM under management, Psilos focuses its investments across the healthcare services, healthcare information technology, and medical technology sectors. Psilos invests nationwide in businesses that are poised to create enduring market value by fundamentally improving the U.S. healthcare system. Our portfolio companies are sustainable and high-value businesses that have a demonstrated ability to reduce the costs of healthcare delivery, improve clinical quality and advance the alignment of payer, patient and provider incentives. Psilos has offices in New York, the San Francisco Bay Area and Santa Fe, New Mexico.

For more information, contact:

Maria Malavenda

SVP, Marketing

HealthEdge

781-419-6134

mmalavenda@healthedge.com


'/>"/>
SOURCE HealthEdge
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Seattle-Based Law Firm Williams Kastner Receives Significant Defense Verdict in Trade Secret Business Litigation Case
2. Arkion(R) Life Sciences Receives Crisis Exemption to US EPA Section 18 Approval in Mississippi and Tennessee to Market Avitec Corn Seed Treatment
3. QMed, Inc. Receives NASDAQ Delisting Letter
4. Ezra Susser, MD, DrPH, receives Distinguished Investigator Award from NARSAD
5. Compensation Risk Managers, LLC Receives Notice of Administrative Action by New York Workers Compensation Board
6. Tasker Products Receives USDA Consent to Begin Immediate Commercialization of Tasker Clear Throughout Entire Poultry Processing Operations
7. Draeger Receives Frost & Sullivan Consumer Award for Respiratory Protection
8. Easter Seals Receives $1 Million Donation From CVS Caremark Charitable Trust to Enhance Autism Services for Children
9. African medical research and training receives Wellcome boost
10. Sen. Robert Byrd Receives AOA Health Care Leadership Award
11. Reproductive Science Center of New England Receives Ambulatory Health Care Accreditation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... 20, 2017 , ... “The Land of More and More”: a brilliant ... hunger, and shares the simple and achievable answer. “The Land of More and More” ... Fairview Missionary Church in Angola, Indiana where he works with the children’s ministry department. ...
(Date:1/19/2017)... ... January 20, 2017 , ... Today, the Centers for Medicare & Medicaid Services ... Alternative Payment Models (APMs) in 2017. Clinicians who participate in APMs are paid for ... part of the Administration’s effort to build a system that delivers better care and ...
(Date:1/19/2017)... ... January 19, 2017 , ... Next week after January 20th, the ... Congressional political games that circumvent health needs of over 30 million. Many interviews with ... anxieties and needs government public servants were suppose to prioritize. Interviews provided below. ...
(Date:1/19/2017)... ... January 19, 2017 , ... With the cold weather here, many people will have ... are efficient when clearing large amounts of snow, but they can be dangerous when used ... Consumer Product Safety Commission for the proper use of snow blowers:, , ...
(Date:1/19/2017)... ... January 19, 2017 , ... LabRoots ... scientists from around the world, announces the launch of its newly redesigned website. ... portal to research breakthroughs and trending news, vital information on upcoming virtual events ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Report Details ... ... for Leading Companies – our new study reveals trends, ... issues and events affecting the Alzheimer,s disease therapeutics and ... answer these key questions: - How is the Alzheimer,s ...
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... , January 19, 2017 ... ; European Oncology & Haematology, 2016;12(Suppl 2):3-8; ... ... Published recently in a ... peer-reviewed journal from touchONCOLOGY, an article by ...
Breaking Medicine Technology: